Giiant Pharma Inc

Inversago Pharma Inc. is a biopharmaceutical company based in Montréal, Canada, focused on developing innovative treatments for patients suffering from metabolic and fibrotic diseases. The company is at the forefront of developing therapies that target the inhibition of peripheral CB1 receptors to alleviate complications associated with metabolic disorders. The company's primary program, INV202, is currently undergoing Phase 2 studies for treating diabetes and associated conditions. Inversago Pharma aims to advance its pipeline of CB1 receptor inhibitors to improve the quality of life for patients affected by various metabolic diseases, including type 1 and type 2 diabetes, non-alcoholic fatty liver disease, and fibrotic diseases. Generated from the website

Angiochem Inc is a biotechnology company based in Montréal, QC, specializing in the development of novel peptide-drug conjugates for the treatment of neurological diseases and disorders. The company's research focuses on utilizing its proprietary platform technology to create innovative therapies that target the blood-brain barrier to deliver drugs directly to the central nervous system. Generated from their business information

Raya Therapeutic Inc is a biotechnology company based in Montréal, QC, specializing in the development of innovative therapeutics. The company is focused on addressing unmet medical needs through cutting-edge research and clinical advancements. With a commitment to improving patient outcomes, Raya Therapeutic Inc aims to create groundbreaking solutions that enhance the quality of life for individuals facing serious health challenges. Their dedicated team works tirelessly to advance their pipeline and foster collaboration within the scientific community. Generated from the website